Metadata[+] Show full item record
Since 2010 the new antimicrobials introduced have activity against resistant Gram negative bacteria, long half-lives against Gram positive bacteria, better activity against Clostridium difficile, and safer antifungal properties. Limiting factors to using the new antimicrobials include lack of susceptibility testing, cost and reimbursement issues. This article describes the new antimicrobials an internist will have contact with.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.